Hong Kong-listed EC Healthcare (submission dated 05 October 2026) filed its Monthly Return for the period ended 30 September 2026, showing no movements in either authorised or issued share capital.\n\nAuthorised Capital – The company’s authorised share capital remained at 38.00 billion ordinary shares with a par value of HKD 0.00001 each, equivalent to HKD 0.38 million. No increase or decrease was recorded during the month.\n\nIssued Shares – Issued shares (excluding treasury shares) stood unchanged at 1,185.21 million. The group continues to hold no treasury shares, keeping total issued shares at the same level. Consequently, there was no change in market capital base arising from share issuance or buy-backs.\n\nPublic Float – EC Healthcare confirmed compliance with the Main Board’s minimum 25% public float requirement as at 30 September 2026.\n\nEquity-linked Instruments – The company’s outstanding share options totalled 78.18 million, split between the 19 February 2016 scheme (18.92 million options) and the 29 May 2023 scheme (59.26 million options). No options were exercised in September, resulting in zero new shares issued and zero proceeds raised. There were no warrants, convertible securities, or other equity-linked instruments outstanding or transacted during the month.\n\nTreasury Activity – The filing recorded no repurchases, cancellations, or transfers involving treasury shares.\n\nCompliance Statement – The board confirmed that all share-related activities complied with Hong Kong Listing Rules and relevant legal requirements.